Leadership Shakeup Fuels IPO Plans

Practo is reshaping its leadership team and adding new board members, signaling a major shift ahead of its planned Initial Public Offering (IPO) in the second half of 2026. These leadership changes, alongside ambitious growth targets, point to a move beyond its roots as a doctor discovery platform towards becoming a comprehensive, AI-powered consumer health service.

Over the past year, Practo has brought in five key executives, including a global COO and CMO from major Indian tech companies, plus a VP of AI and a Chief Product and Technology Officer. Former Union Health Secretary C.K. Mishra also joined the board as an independent director. These additions strengthen the company's leadership for its upcoming phase. These moves are linked to Practo's ambitious financial goals: reaching an annual GMV run-rate of $1 billion by June 2026, with its U.S. operations expected to add $250-300 million. This marks a significant increase from about $400 million GMV last year. This strategic shift aims to prepare Practo for a potential IPO by late 2026, requiring strong operational results and clear governance. The company reported revenue of roughly INR 240 crore in FY24, with net losses shrinking to INR 17 crore. It also reported operating EBITDA profit of INR 15 crore in FY25 on INR 234 crore revenue, along with positive cash flows.

Market Opportunity and AI Strategy

Practo operates in India's rapidly growing digital health market, valued at an estimated $14.5 billion in 2024 and forecast to reach over $106 billion by 2033, growing annually by more than 25%. The wider health-tech market is even larger, projected to grow from $6.5 billion in 2024 to over $78 billion by 2033, at a rate of nearly 29% annually. A key part of Practo's strategy is integrating Artificial Intelligence (AI). The AI segment in Indian healthcare is expected to grow by over 40% annually, reaching $1.6 billion by 2025. Practo is using AI for features like smart search, symptom checking, and clinical feedback to improve user experience and efficiency. This AI focus supports Practo's goal of becoming a full-service consumer health brand, emphasizing a better patient experience rather than just expanding its reach. Competitors include Tata 1mg in pharmacy, Apollo 24x7 in integrated care, and MediBuddy with employer partnerships. However, Practo's existing provider software and discovery platform offer a distinct advantage. The company has secured $228 million across 10 funding rounds, with recent discussions valuing it around $700 million, up from a lower valuation in 2020.

Challenges and Competition

Despite recent operational profits, Practo faces strong competition. The health-tech market includes major players like Tata 1mg, Apollo 24x7, and PharmEasy, all competing for customers. While Practo aims for $1 billion in GMV, competitors are also growing quickly with substantial funding and different ways of making money. Practo's previous valuation challenges suggest it might be difficult to achieve and maintain high valuations in the public market. Although Practo has reported profitable months and positive operating earnings before interest, taxes, depreciation, and amortization (EBITDA) in FY25, specific net profit details haven't been released, raising questions about its overall profitability. Expanding into the U.S. presents challenges, including navigating the complex American healthcare regulations and building international revenue while staying profitable. Relying on GMV targets shows platform activity but doesn't guarantee strong revenue or consistent profits. Practo also needs continuous investment in technology and AI to stand out in a rapidly changing industry.

Path to Public Markets

Practo's leadership changes and strategic focus signal a clear move towards its planned IPO in the second half of 2026. Its strategy centers on using AI to enhance patient experience and expanding internationally, especially in the U.S., which are crucial for its growth. Achieving operational profitability and positive cash flow improves its prospects for going public. Ultimately, Practo's success will depend on turning these plans into consistent financial results, managing competition, and performing well in the evolving health-tech market.